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In the course of an ethnobotanical study on fungi used in Yemeni ethnomedicine the fungus Podaxis
pistillaris (Podaxales, Podaxaceae, Basidiomycetes) was found to exhibit antibacterial activity against
Staphylococcus aureus, Micrococcus flavus, Bacillus subtilis, Proteus mirabilis, Serratia marcescens
and Escherichia coli. In the culture medium of P. pistillaris three epidithiodiketopiperazines were iden-
tified by activity-guided isolation. Based on spectral data (NMR, ESI-MS and DCI-MS) their identity
was established as epicorazine A (1), epicorazine B (2) and epicorazine C (3, antibiotic F 3822), which
have not been reported as constituents of P. pistillaris previously. It is assumed that the identified com-
pounds contribute to the antibacterial activity of the extract.
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Introduction
In our continuing study of plants and fungi used in traditional
medicine in Yemen (1–5), we selected the fungus Podaxis pis-
tillaris (L. Pers.) Morse agg. for an in depth investigation. This
fungus is spread in semideserts of Africa, Asia, Australia and
America. In Yemen it can be found in arid zones. No species
of this genus has been found in Europe and Japan (6).
The fruiting bodies of P. pistillaris are used in some parts of
Yemen for the treatment of skin diseases, in South Africa as
folk medicine against sunburn and in China to treat inflamma-
tion (5,7,8). In other countries, e.g. India, Afghanistan and
Saudi Arabia, they are used as food (9,10). In Australia, the
fungus was used by many desert Aborigines to darken the
white hair in the whiskers of old men, for body painting and
as a fly repellent (11). The fruiting bodies are known to be
rich in proteins containing all essential amino acids, carbo-
hydrates, lipids and minerals (12). Antimicrobial activities
against Pseudomonas aeruginosa and Proteus mirabilis have
been found (13). On the other hand, there is information
from Nigeria and South Africa about a possible toxicity (14).
A high value for total lanthanides was measured in this mush-
room (75 mg kg
 1 dry weight) (15). Cultivation assays of the
fruiting bodies have been successful (16,17). But no phyto-
chemical studies of P. pistillaris have been reported till now.
In order to get enough and reproducible material for phyto-
chemical and biological studies we established mycelial cul-
tures of P. pistillaris, expecting that the cultures will produce
the same metabolites as the fruiting bodies. Here, we report
on the antibacterial and cytotoxic activities of extracts and
isolated metabolites, the isolation of three antibacterial
epicorazines from the culture medium and the possible
implications on safety.
Materials and Methods
General
Thin layer chromatography (TLC) was carried out on silica gel
60 F254 plates (Merck) with the solvent EtOAc/toluene/HOAc
(7:3:0.1). Chromatograms were inspected under UV light
at wavelengths 254 and 366 nm, and by spraying with
anisaldehyde–H2SO4 reagent. CC was carried out on Sephadex
For reprints and all correspondence: U. Lindequist. Tel: þ49-3834-864868;
Fax: þ49-3834-864885; E-mail: lindequi@uni-greifswald.de
  The Author (2006). Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access
version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press
are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety
but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.orgLH-20 (Pharmacia Biotech). IR spectra were recorded in KBr
on a Perkin-Elmer FTIR 1650 spectrometer and UV spectra
in MeOH with a Uvikon 930 spectrometer.
1H- and
13C-
NMR spectra were obtained on a Bruker Spectrometer AM
400 with the solvent signal as internal reference. MS spectra
were recorded on a Finnigan MAT 95 spectrometer (Finnigan
MAT GmbH; Bremen), CD spectra on a circular dichrograph
J-710 (Jasco Corp., Tokyo). Optical rotations were measured
on a Perkin-Elmer 241 MC polarimeter at room temperature.
M.p.s were recorded on a Kofler apparatus.
Fruiting Bodies
Fruiting bodies of P. pistillaris were collected from Aden
region, Yemen, during the rainy season in February 1999.
They were identified by Prof. H. Kreisel (Institute of Micro-
biology, Ernst-Moritz-Arndt-University, Greifswald). A
voucher specimen is deposited at the Department of Pharma-
ceutical Biology (Ernst-Moritz-Arndt-Universita ¨t, Greifswald,
Germany).
Pieces of the fruiting bodies were isolated and placed on
solid HAGEM medium (18) in Petri dishes. After cultivation
for 3 weeks at room temperature, the mycelium was removed
from the agar plates and transferred into a liquid medium con-
taining 5% glucose and 5% malt extract in distilled water
adjusted to pH 5.4. The cultures were incubated for 3 weeks
at 25 C on a rotary shaker (125 r.p.m.).
Extraction and Isolation
The culture medium was separated from the mycelium by fil-
tration and extracted with ethyl acetate. The extract was dried
over Na2S04 and evaporated under reduced pressure. The
resulting concentrate (0.5 g) was passed through Sephadex
LH-20 using n-hexane/CH2C12 (1:2) as eluent to give five
fractions (A–E). Fraction B (50 mg) was separated on a
Sephadex LH-20 column with MeOH as the eluent to yield
2.5 mg of epicorazine A (1) (Fig. 1). Further purification of
fraction C (30 mg) on Sephadex LH-20 with CH2Cl2/MeOH
(2:1) yielded (1.5 mg) epicorazine B (2) (Fig. 2). Fraction E
was separated on a Sephadex LH-20 column with CH2C12/
MeOH (2:1) and yielded epicorazine C (3) (Fig. 3).
Epicorazin A (1), white crystals, melting point (mp)
197–198 C, TLC: EtOAc/toluene/HOAc (7:3:0.1) Rf ¼ 0.72
(brown spot after spraying with anisaldehyde–H2SO4 reagent
and heating); UV (MeOH) lmax (lg e): 215 (4.42) and
260 (3.65) nm. IR (KBr) nmax: 3360, 1690, 1410, 1380, 1365,
1250, 1195, 1185, 1140, 1095, 1030 and 810 cm
 1;N M R
(Table 2); MS: EI-MS (200 C): m/z (%) ¼ 420 (0.5) M
þ,
356 (100) (M   S2)
 ,(  )-DCI (NH3): m/z (%) ¼ 420 (100)
(M)
 , 356 (22) (M   S2)
 ,( þ)-DCI (NH3): m/z (%) ¼ 438
(21) (M þ NH4)
þ, 421 (5) (M þ H)
þ, 357 (43)
(M þ H   S2)
þ, 296 (100).
Epicorazin B (2), white crystals, mp 192–193 C, TLC:
EtOAc/toluene/HOAc (7:3:0.1) Rf ¼ 0.65 (brown spot after
spraying with anisaldehyde–H2SO4 reagent and heating); UV
(MeOH) lmax (lg e): 220 (2.83) nm. IR (KBr) nmax: 3450,
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Figure 2 Epicorazines B (2)
88 Podaxis pistillaris3360, 1690, 1670 and 1370 cm
 1; NMR (Table 3); MS: EI-MS
(200 C): m/z (%) ¼ 356 (100) (M   S2)
þ,(  )-DCI (NH3): m/
z (%) ¼ 420 (100) (M)
 , 355 (16) (M   H   S2)
 ,
(þ)-DCI (NH3): m/z (%) ¼ 438 (7) (M þ NH4)
þ, 110 (100).
Epicorazin C (3), glassy material, TLC: EtOAc/toluene/
HOAc (7:3:0.1) Rf ¼ 0.45 (brown spot after spraying with
anisaldehyde–H2SO4 reagent and heating), NMR (Table 4);
MS: EI (200 C): m/z (%) ¼ 374 (91), 356 (100). ( )-DCI
(NH3): m/z (%) ¼ 438 (100), 420 (17), 373 (15). (þ)-DCI
(NH3): m/z (%) ¼ 456 (100) (M þ NH4)
þ, 150 (100).
Determination of Antibacterial Activity
The following bacterial strains were used: Staphylococcus aur-
eus (ATCC 29213), Micrococcus flavus (SBUG 16), Bacillus
subtilis (SBUG 14), P. mirabilis (SBUG 47), Serratia marces-
cens (SBUG 9) and Escherichia coli (ATCC 25922).
A modified agar diffusion method (19) was used to deter-
mine the antibacterial activity. Sterile nutrient agar (Immun-
pra ¨parate, Berlin; 26 g l
 1 agar in distilled water) was
inoculated with bacterial cells (200 ml of bacterial cell suspen-
sion in 20 ml medium) and poured into Petri dishes to give a
solid plate. An aliquot of 40 ml of test material dissolved in
methanol (equivalent to 1 mg of the dried extract or 100 mg
of pure compounds) was applied on sterile paper discs (6 mm
diameter; Schleicher and Schuell, Ref. No 321860). Methanol
was allowed to evaporate and the discs were deposited on the
surface of inoculated agar plates. The plates were kept for 3 h
in a refrigerator at 6 C to enable prediffusion of the substances
into the agar and were then incubated for 24 h at 37 C. Ampi-
cillin and gentamycin were used as positive and the solvent
methanol as negative control. At the end of the incubation
time inhibition zone diameters around each of the disc (dia-
meter of inhibition zone minus diameter of the disc) were
measured and recorded. An average zone of inhibition was cal-
culated for the three replicates. An inhibition zone of 8 mm or
greater was considered as good antibacterial activity.
The minimum inhibitory concentration (MIC) values were
determined by standard serial broth microdilution assay in
nutrition medium II (SIFIN, Berlin), starting from a 250 mg
ml
 1 solution. The end point in this assay was indicated
by the absence of detectable growth after 18 h of incubation
at 37 C.
Determination of Cytotoxic Activity
Cytotoxicity was measured by the neutral red uptake assay
using FL-cells, a human amniotic epithelial cell line (1,20).
Onlylivingcellsareabletomanagetheactiveuptakeofneutral
red. FL-cells were cultivated in a 96-well microtiter plate
Table 1. Antibacterial activity of the EtOAc extract from the culture medium of Podaxis pistillaris and of epicorazines in agar diffusion assay
Strain Zones of inhibition (mm)
EtOAc extract Epicorazine A Epicorazine B Epicorazine C Ampicillin Gentamicin
1 mg per disk 100 mg per disk 10 mg per disk
Staphyolococcus aureus ATCC 29213 30 ± 3 35 ± 4 30 ± 3 25 ± 3 26 ± 2 n.d.
Micrococcus flavus SBUG 16 20 ± 2 32 ± 3 30 ± 2 22 ± 2 31 ± 3 n.d.
Bacillus subtilis SBUG 14 18 ± 2 35 ± 3 32 ± 3 20 ± 2 28 ± 3 n.d.
Proteus mirabilis SBUG 47 19 ± 3 25 ± 2 24 ± 2 20 ± 2 30 ± 2 n.d.
Serratia marcescens SBUG 9 18 ± 1 20 ± 1 20 ± 2 17 ± 2 n.d. 15 ± 2
Escherichia coli ATCC 25922 18 ± 1 25 ± 2 24 ± 3 18 ± 3 n.d. 14 ± 1
n.d. non detected; n ¼ 9.
Table 2. NMR-data of epicorazine A (1) in CDCl3 (
1H: 300 MHz,
13C: 75 MHz)
H dH (p.p.m.) m J (Hz) C dC (p.p.m.) m HMBC-correlated H dC
a (p.p.m.)
—— — — 1 193.69 s 6, 7a, 5 (3) 194.5
2 6.14 dd 2.4, 10.2 2 129.30 d 4-OH (163 Hz)
b 129.5
3 6.94 dd 1.9, 10.2 3 150.75 s 4-OH, 4 (165 Hz)
b 151.3
4 4.79 ddt 8.2, 1.6, 1.9 4 71.13 d 4-OH, 5, 6 71.3
4-OH 5.84 d 1.3 —— —— —
5 3.81 dd 12.8, 8.2 5 69.43 d 6, 7b (3) 69.9
6 3.26 dt 5.6, 12.8 6 48.97 d 7aþb (2, 5) 49.2
7a 3.03 dd 12.8, 14.8 7 31.08 t — 31.0
7b 2.59 dd 5.6, 14.8
— —— — 8 75.81 d 7aþb 76.6
— —— — 9 164.27 s 7a 165.2
aIn dioxane see (20), the
1H-NMR data given by Deffieux et al. were obtained in acetone-dd, where several signals overlap especially at 90 MHz. According to our
spectra their assignment of the partially overlapping 2- and 20-protons has to be exchanged;
bdirekt
1JH,C coupling.
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5 cells per ml EAGLE-MEM, Sifin, Berlin; 150 ml per well)
at 37 C in a humidified 5% carbon dioxide atmosphere. The
EAGLE-MEM was completed by l-glutamine (0.1 g l
 1),
HEPES(2.38gl
 1),penicillinG(10
5IEl
 1),streptomycinsul-
fate (0.10 g l
 1) and FCS (Gibco; 80 ml l
 1). After 24 h, 50 ml
of the solution of test substance or medium with equal amounts
of ethanol (control) were added. After a further incubation for
72 h the cells were washed three times with phosphate buffered
saline (PBS) solution. An aliquot of 100 ml of neutral red solu-
tion (SERVA, 0.3% in EAGLE-MEM) was added per well.
The cells were then incubated for 3 h at 37 C, followed by
another three times washing with PBS. Hundred microliters
of a solution of acetic acid (1%, v/v) and ethanol (50%, v/v)
in distilled water were added. After shaking for 15 min the
optical density was measured at 540 nm with an ELISA-
Reader-HT II (Anthos Labtec Instruments, Salzburg). The
mean of four measurements for each concentration was
determined (n ¼ 3). IC50 values (concentration that caused a
50% inhibition of growth compared with controls) were calcu-
lated with the help of micro cal. Origin program.
Results
Biological Activities
Unlike the extracts from the mycelium (DCM, EtOH, aqueous)
the EtOAc extract from the culture medium of P. pistillaris
showed a strong antibacterial activity against several Gram-
positive and Gram-negative bacteria (S. aureus ATCC
29213, M. flavus SBUG 16, B. subtilis SBUG 14, P. mirabilis
SBUG 47, S. marcescens SBUG 9 and E. coli ATCC 25922;
Table 1). Bioactivity-guided fractionation of this extract led
to the isolation and structural elucidation of three pure sub-
stances (1–3) related to the antibacterial activity. The com-
pounds were identified as epicorazines A, B and C (see
below). In the agar diffusion assay the epicorazines are active
against all bacteria tested (Table 1). The MIC against S. aureus
is 25 mgml
 1for epicorazine A (1), 50 mgml
 1for epicorazine
B( 2) and 75 mgm l
 1 for epicorazine C (3) (MIC ampicillin
0.05 mgm l
 1). For a further evaluation of the biological acti-
vities of extract and isolated compounds their cytotoxicity
was measured in the neutral red assay using cultivated human
amnion epithelial cells (FL cells). All tested samples showed
remarkable cytotoxicity. Ten microgram per milliliter of the
extract caused the death of all FL cells. The IC50 against FL
cells is 10 mgm l
 1 for epicorazin A (1) and B (2).
Isolation and Structure Elucidation of Epicorazines
Compound 1 was obtained as white crystals melting at
197–198 C. All well-resolved NMR signals of 1 in CDCl3
could be assigned and correlated by
1H,
1H-COSY,
1H,
13C-
HMQC and
13C-HMBC NMR spectroscopy (Table 2), and
thus provided the carbon skeleton from C-1 to C-9. DCI-MS
Table 3. NMR data of epicorazine B (3)
H dH
a (ppm) m J (Hz) C dC
a (ppm) m HMBC-correlated H dH
b (ppm) m J (Hz)
— —— — 1 193.70 s 6, 7a/b — — —
2 6.14 dd 10.3, 2.0 2 129.28 d — 6.07 dd 10.3, 2.3
3 6.94 dd 10.3, 1.8 3 150.77 d 4-OH, 4 6.91 dd 10.3, 1.9
4 4.79 ddt 8.1, 1.8, 1.8c 4 71.16 d 4-OH, 5, 6 4.77 ddt 8.5, 2.0, 2.0
c
4-OH 5.88 s —
c — — — — 5.22 s —
c
5 3.79 dd 13.0, 8.1 5 69.51 d 7a/b, 6. 3 3.98 dd 13.1, 8.5
6 3.26 dt 5.7, 12.7 6 49.02 d 7a/b, 2 3.41 dt 5.8, 12.7
7a 3.01 dd 15.0, 12.5 7 30.81 t 6 2.98 dd 14.5, 12.7
7b 2.60 dd 15.0, 5.7 2.55 dd 14.5, 5.8
— —— — 8 76.19 s 7a/b — — —
— —— — 9 164.67 s 7a — — —
— —— — 10 193.36 s 60,7 0a/b — — —
20 6.17 dd 10.4, 2.0 20 128.41 d — 6.11 dd 10.3, 1.1
30 6.88 dd 10.4, 2.3 30 148.77 d 40 6.97 dd 10.3, 4.1
40 4.90 dd 6.5, 2.4 40 67.73 d 50,2 0,6 0 5.23 m —
c
40-OH —
d —— — — — — 4.78 d 5.7
50 4.68 dd 9.7, 6.5 50 65.82 d 70b, 30,6 0 4.67 dd 7.2, 4.9
60 3.38 ddd 9.7, 9.7, 8.0 60 44.47 d 70a/b, 20 3.44 ddd 8.5, 7.2, 5.6
70a 2.60 dd 8.0, 14.6 70 33.68 t 50,6 0 2.55 dd 5.6, 14.4
70b 3.55 dd 9.7, 14.6 3.36 dd 8.5, 14.4
— —— — 80 75.88 s 50,7 0a/b — — —
— —— — 90 163.76 s 70a/b — — —
aIn CDCl3 (
1H: 400 MHz,
13C: 100 MHz);
bin acetone-d6 (600 MHz);
cbroad;
da corresponding OH signal was not observed.
90 Podaxis pistillarisspectrometry indicated a molecular mass of 420. This mass
was rarely present in the EI mass spectrum, which was domin-
ated by a fragment ion at m/z 356 corresponding to the loss of
S2. With these data, 1 was recognized as the symmetrical
epidithiodiketopiperazine antibiotic epicorazine A (1), previ-
ously isolated from the fungus Epicoccum nigrum (21). Com-
parison of our data with the
13C-NMR data of 1 in dioxane-
d8 (10) and
1H-NMR data in acetone-d6 (22) confirmed this
identification, including the same relative configuration,
which was indicated by the vicinal coupling constants.
Additionally, 1 furnished the same CD curve as given for
epicorazine A (1) in (22) and thus showed that these com-
pounds from different sources have the identical absolute
configuration.
A second compound 2, isolated as white crystals melting at
192–193 C showed the same molecular mass and fragmenta-
tion behavior during mass spectrometry. It was identified as
epicorazine B (2) (23) from its NMR data given in Table 3.
Although the molecule halves are identical except their chira-
lity, all
1H-NMR signals of 2 were well resolvedat 400 MHz in
CDCl3, and thus provided the complete proton coupling data
indicating the relative configuration. The absolute configura-
tion was confirmed by CD spectroscopy.
Further traces of another variant 3 were isolated as glassy
material. The molecular ion at m/z 438 suggested the formal
addition of water. This was supported by the
1H-NMR spectra
of 3 inDMSO-d6 and in DMSO-d6with D2O forH/Dexchange
(Table 4), where one part of the molecule showed the signals
known from 1 while the remaining
1H-NMR signals and their
correlations from a
1H,
1H-COSYspectrum identified the other
part of 3 as a saturated b-hydroxy-variant. Thus, 3 was recog-
nized as epicorazine C, which has been isolated from Stereum
hirsutum (24) and as antibiotic F 3822 from a strain of
Epicoccum purpurascens (25). In order to designate the
relative configuration, the coupling constants were studied.
The sharp dd signal of 50-H shows a coupling constant of
5 Hz with 40-H and of 7 Hz with 60-H. This indicates a cis-
configuration of protons 50-H and 60-H. As in 1 the trans-
configuration of protons 5-H and 6-H in the other part of 3 is
evident by a coupling constant of 13 Hz. Biological activities
of isolated compounds.
Discussion
Herbal remedies used in the traditional folk medicine provide
an interesting and still largely unexplored source for the cre-
ation and development of potentially new drugs (26). But it
is necessary to reveal the active principles by isolation and
characterization of their constituents and to validate their
possible toxicity. Up to date, very little research was done
to investigate the traditional medicinal plants and fungi in
Yemen (1–4).
During our study of mycelial cultures of the widely used
mushroom P. pistillaris, which has not been phytochemically
investigated previously, its antimicrobial constituents were
identified as epicorazines A (1), B (2) and C (3). These sub-
stances belong to the group of epipolythiopiperazine-2,5-
diones (ETPs), an important class of biologically active meta-
bolites produced only by fungi [reviewed in (26)]. They occur
as monomers or dimers and are characterized by the presence
Table 4.
1H-NMR data of epicorazine C (3) (antibiotic F 3822)
H DMSO
a DMSO/(D2O)
b DMSO
b,c
d m J (Hz) d m J (Hz) d J (Hz)
2 6.07 dd 10, 2 6.06 dd 10.1, 2.0 6.05 10
3 6.90 dd 10, 2 6.89 dd 9.9, 1.8 6.88 10, 2
4-OH 5.87 s — — — — — —
4 4.68 d 9 br. 4.67 ddd 8.5, 2.2, 2.2 4.67 8, 2
5 3.98 dd 13, 8 3.94 dd 13.7, 9.2 3.96 13, 8
6 3.34 ddd 13, 12, 6 3.34 ddd 12.9, 12.6, 6.0 3.33 13, 12, 6
7b 2.53 m —
d 2.54 m —
d 2.55 17, 5
7a 2.84 dd 14, 12 2.84 dd 14.2, 12.7 2.86 14, 12
20a 2.70 dd 16, 10 2.70 dd 16.3, 10.2 2.69 17, 10
20b 2.53 m —
d 2.54 m —
d 2.51 14, 6
30 3.71 ddd 10, 5, 5, 2 3.71 ddd 10.4, 4.3, 1.8 3.76 10, 5, 2
30-OH 5.14 d 5 — — — — —
40 4.78 ddd 5, 5, 2, 1 br 4.77 d 4.6 br 4.73 5, 2
40-OH 5.46 d 5 — — — — —
50 4.40 dd 7, 5 4.41 dd 7.1, 4.6 4.43 8, 5
60 3.17 dddd 8, 7, 2, 2 3.18 ddd 7.8, 7.5, 2.4 3.18 8, 3
70a 2.99 dd 15, 8 2.99 dd 14.2, 8.1 3.02 15, 8, 2
70b 2.79 dd 15, 2 2.79 dd 14.5, 2.3 2.79 15, 3
a600 MHz;
b400 MHz;
cJapan. Pat. 91-227 991;
doverlap of 20b- and 7b-H.
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only in some strains of E. nigrum (21–23), E. purpurascens
(25,27) and in S. hirsutum (24).
ETPs, their mostly investigated representative is gliotoxin,
show a broad range of biological activities including anti-
fungal, antibacterial and antiviral activities. In mammalian
systems they display potent in vitro and in vivo immunosup-
pressive activity, induce apoptosis and possess anticancer
activity. They may be produced in vivo during the course of
fungal infections and contribute to the etiology of the disease.
Gliotoxin appears to be a virulence factor associated with
invasive aspergillosis of immunocompromised patients. The
mode of actions of ETPs seems to be the inhibition of thiol
requiring enzymes by covalent interaction to sulfhydryl groups
of proteins and the formation of reactive oxygen species
[reviewed in (25)].
The broad-spectrum of activities and the toxicity of
most members of the ETP class ruled them out for clinical
use as antimicrobial, immunosuppressive or anticancer agents
till now.
With respect to the traditional medicine of Yemen our
investigations confirm the biological activity and justify the
ethnomedicinal use of P. pistillaris. We assume that the iden-
tified epicorazines contribute to the observed antibacterial
effects of this mushroom. Because of cytotoxic and other
undesired effects of epicorazines the results raise doubts about
the usefulness of P. pistillaris as food (additive) and medicine.
In vivo investigations of possible toxicity are strongly
recommended. Such cautious are equally applicable to com-
pounds derived from mushrooms (29) and white cedar (30).
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